|
|
|
|
 |
 |
Intezyne Technologies is led by its Management team including CEO Habib Skaff and CSO Kevin Sill. In order to further strengthen Intezyne's executive team and guide the Company during its growth and development, an experienced Board of Directors and Scientific Advisory Board have been assembled. The Board of Directors is currently comprised of the two members of the Management team and four outside members with expertise in the pharmaceutical and biotechnology industry, IP establishment and protection, and business development. In addition to the Board of Directors, a Scientific Advisory Board has been established and includes individuals with expertise in a wide range of scientific disciplines. The members are leaders in their respective fields and aid Intezyne in its continued growth and development in its scientific endeavors.
PEOPLE
 |
 |
Habib Skaff, Ph.D.
Chief Executive Officer |
Kevin Sill, Ph.D.
Chief Science Officer |
|
|
|
|
